These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 25341709)

  • 21. Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - a contemporary experience.
    Cohen MG; Singh V; Martinez CA; O'Neill BP; Alfonso CE; Martinezclark PO; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):987-93. PubMed ID: 23729031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.
    Shah AM; Ogbara J; Herrmann HC; Fox Z; Kadakia M; Anwaruddin S; Bavaria JE; Desai ND; Jagasia D; Szeto WY; Li RH; Vallabhajosyula P; Giri J
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):888-94. PubMed ID: 25963625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement.
    Muneretto C; Bisleri G; Moggi A; Di Bacco L; Tespili M; Repossini A; Rambaldini M
    Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):90-5. PubMed ID: 25320140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients.
    Abdul-Jawad Altisent O; Ferreira-Gonzalez I; Marsal JR; Ribera A; Auger C; Ortega G; Cascant P; Urena M; Del Blanco BG; Serra V; Sureda C; Igual A; Rovira A; González-Alujas MT; Gonzalez A; Puri R; Cuellar H; Tornos P; Rodés-Cabau J; Garcia-Dorado D
    Clin Res Cardiol; 2016 Jun; 105(6):508-17. PubMed ID: 26646556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation.
    Erdoes G; Basciani R; Huber C; Stortecky S; Wenaweser P; Windecker S; Carrel T; Eberle B
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):778-83; discussion 783-4. PubMed ID: 22423058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement.
    Lardizabal JA; Macon CJ; O'Neill BP; Desai H; Singh V; Martinez CA; Alfonso CE; Cohen MG; Heldman AW; O'Neill WW; Williams DB
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1226-30. PubMed ID: 25511236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How embolism proof is the Embrella Embolic Deflector system?
    Van Mieghem NM; van der Lugt A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1156-8. PubMed ID: 25341710
    [No Abstract]   [Full Text] [Related]  

  • 30. Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement.
    Flaherty MP; Mohsen A; Moore JB; Bartoli CR; Schneibel E; Rawasia W; Williams ML; Grubb KJ; Hirsch GA
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):118-29. PubMed ID: 25204308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral emboli detection and autonomous neuromonitoring using robotic transcranial Doppler with artificial intelligence for transcatheter aortic valve replacement with and without embolic protection devices: a pilot study.
    Baig AA; Manion C; Khawar WI; Donnelly BM; Raygor K; Turner R; Holmes DR; Iyer VS; Hopkins LN; Davies JM; Levy EI; Siddiqui AH
    J Neurointerv Surg; 2024 Oct; 16(11):1167-1173. PubMed ID: 37940386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study.
    Pinter L; Ribo M; Loh C; Lane B; Roberts T; Chou TM; Kolvenbach RR
    J Vasc Surg; 2011 Nov; 54(5):1317-23. PubMed ID: 21658889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement.
    Szeto WY; Augoustides JG; Desai ND; Moeller P; McGarvey ML; Walsh E; Bannan A; Herrmann HC; Bavaria JE
    J Card Surg; 2011 Jul; 26(4):348-54. PubMed ID: 21793920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging.
    Ghanem A; Müller A; Nähle CP; Kocurek J; Werner N; Hammerstingl C; Schild HH; Schwab JO; Mellert F; Fimmers R; Nickenig G; Thomas D
    J Am Coll Cardiol; 2010 Apr; 55(14):1427-32. PubMed ID: 20188503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: a FRANCE-2 registry substudy.
    Tchetche D; Farah B; Misuraca L; Pierri A; Vahdat O; Lereun C; Dumonteil N; Modine T; Laskar M; Eltchaninoff H; Himbert D; Iung B; Teiger E; Chevreul K; Lievre M; Lefevre T; Donzeau-Gouge P; Gilard M; Fajadet J
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1138-45. PubMed ID: 25240554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major thrombocytopenia after balloon-expandable transcatheter aortic valve replacement: prognostic implications and comparison to surgical aortic valve replacement.
    Jilaihawi H; Doctor N; Chakravarty T; Kashif M; Mirocha J; Cheng W; Lill M; Nakamura M; Gheorghiu M; Makkar RR
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):130-7. PubMed ID: 24677617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral embolic protection in thoracic endovascular aortic repair.
    Grover G; Perera AH; Hamady M; Rudarakanchana N; Barras CD; Singh A; Davies AH; Gibbs R
    J Vasc Surg; 2018 Dec; 68(6):1656-1666. PubMed ID: 29804744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: a comparison with surgical cut-down and closure.
    Nakamura M; Chakravarty T; Jilaihawi H; Doctor N; Dohad S; Fontana G; Cheng W; Makkar RR
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):293-300. PubMed ID: 23873857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of cerebral injury following transfemoral aortic valve implantation.
    Ghanem A; Müller A; Sinning JM; Kocurek J; Becker BV; Vogel M; Vasa-Nicotera M; Hammerstingl C; Schwab JO; Nähle CP; Thomas D; Wagner M; Grube E; Werner N; Nickenig G
    EuroIntervention; 2013 Mar; 8(11):1296-306. PubMed ID: 23538093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial.
    Van Mieghem NM; van Gils L; Ahmad H; van Kesteren F; van der Werf HW; Brueren G; Storm M; Lenzen M; Daemen J; van den Heuvel AF; Tonino P; Baan J; Koudstaal PJ; Schipper ME; van der Lugt A; de Jaegere PP
    EuroIntervention; 2016 Jul; 12(4):499-507. PubMed ID: 27436602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.